InvestorsObserver
×
News Home

Is Apyx Medical Corp (APYX) Stock at the Top of the Medical Devices Industry?

Wednesday, March 27, 2024 02:33 PM | InvestorsObserver Analysts

Mentioned in this article

Is Apyx Medical Corp (APYX) Stock at the Top of the Medical Devices Industry?

The 39 rating InvestorsObserver gives to Apyx Medical Corp (APYX) stock puts it near the middle of the Medical Devices industry. In addition to scoring higher than 45 percent of stocks in the Medical Devices industry, APYX’s 39 overall rating means the stock scores better than 39 percent of all stocks.

Overall Score - 39
APYX has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on APYX!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 39 would rank higher than 39 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Apyx Medical Corp Stock Today?

Apyx Medical Corp (APYX) stock is trading at $1.35 as of 2:29 PM on Wednesday, Mar 27, a gain of $0.07, or 5.08% from the previous closing price of $1.28. The stock has traded between $1.28 and $1.42 so far today. Volume today is light. So far 156,615 shares have traded compared to average volume of 229,614 shares. Click Here to get the full Stock Report for Apyx Medical Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App